Actavis Acquires Botox Maker Allergan Pharmaceuticals

Actavis Acquires Botox Maker Allergan Pharmaceuticals

November 19, 2014
By Beverly Brooks
The Plastic Surgery Channel

Some changes are in the works for Botox® maker Allergan. Botox, the gold standard for non surgical removal of frown lines, will now be run by pharmaceutical giant Actavis, in what’s perceived as a positive move by many board certified plastic surgeons.

wp2“Despite market trends and shareholder demands, Allergan has remained focused on research and development,” says Caroline Glicksman, MD, a board certified plastic surgeon in New Jersey. “It is my sincere hope that their commitment to our patients through medical innovation continues after the acquisition by Actavis.”

Allergan Dodges Hostile Takeover by Valeant

Allergan dodged a hostile takeover by another pharma company Valeant Pharmaceuticals, Inc., with a recent offer valued at $54 billion.

Hundreds of letters from the medical community expressed concern about Valeant Pharmaceuticals.  The disagreement revolved around fears that Valeant would sharply cut Allergan’s funding in research-and-development.

“Research, development, and clinical education have always been very important for Allergan, which is why the Valeant hostile bid was disconcerting,” says Pat McGuire, MD, a board certified plastic surgeon in St. Louis.

SONY DSCWill Actavis Support Botox® and Research?

“Actavis seems to have a similar philosophy to Allergan, with a strong commitment to research and development, so this appears to be a positive merger,” says Dr. Pat McGuire.

“I work for an innovative company — that’s why I’m working for Allergan,” says Philippe Schaison, President of U.S. Medical for Allergan, “I’m all about science, and we have the duty to bring innovation to patients and physicians.”

While Botox is a game changer when it comes to eliminating frown lines, Allergan has also captured a huge market share with the recent introduction of JUVÉDERM VOLUMA® XC to the United States. Voluma is the first and only FDA-approved injectable gel to instantly add volume to the cheek area and give the face a subtle lift for up to two years.

Allergan also recently launched SERI Surgical Scaffold, a bio-degradable material used in procedures requiring tissue support in the breast and abdomen.

The recent acquisition is perceived as a win-win in many medical circles because it positions Actavis as a top ten global pharmaceutical company, with more than a dozen medical advances already in the ‘pipeline’ or development stage.

Click to add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

More in

Men, Plastic Surgery, and Masculinity.

Men, Plastic Surgery, and Masculinity

Katherine StuartDecember 14, 2017

How Can Plastic Surgeons Help Back Pain?

John HammarleyDecember 13, 2017
The Latest Advances in Surgical Neck Rejuvenation.

The Latest Advances in Surgical Neck Rejuvenation

Anne MeyerDecember 12, 2017
How and Why Surgeons Decide Between Modern Implants.

How and Why Surgeons Decide Between Modern Implants

Brooke R. Seckel, MDDecember 11, 2017
Is There a Need for Government Regulation with "Cosmetic Surgeons"?

Is There a Need for Government Regulation with “Cosmetic Surgeons”?

Kevin L. Smith, MDDecember 8, 2017

Implant Placement Debate: Over vs. Under the Muscle

Katherine StuartDecember 7, 2017
The options: paying for plastic surgery.

The Options: Paying for Plastic Surgery

Dawn TongishDecember 6, 2017
New Eyes, New You with a Blepharoplasty.

New Eyes, New You with a Blepharoplasty

Katherine StuartDecember 5, 2017
The AeroForm tissue expander says "no more" to injections.

The AeroForm Tissue Expander Says “No More” to Injections

Jason Cooper, MDDecember 4, 2017